Cargando…

Development and clinical validation of CT-based regional modified Centiloid method for amyloid PET

BACKGROUND: The standard Centiloid (CL) method was proposed to harmonize and quantify global (18)F-labeled amyloid beta (Aβ) PET ligands using MRI as an anatomical reference. However, there is need for harmonizing and quantifying regional Aβ uptakes between ligands using CT as an anatomical referenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Soo-Jong, Ham, Hongki, Park, Yu Hyun, Choe, Yeong Sim, Kim, Young Ju, Jang, Hyemin, Na, Duk L., Kim, Hee Jin, Moon, Seung Hwan, Seo, Sang Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585745/ https://www.ncbi.nlm.nih.gov/pubmed/36266688 http://dx.doi.org/10.1186/s13195-022-01099-0

Ejemplares similares

Appropriate reference region selection of (18)F-florbetaben and (18)F-flutemetamol beta-amyloid PET expressed in Centiloid
por: Cho, Soo Hyun, et al.
Publicado: (2020)

Centiloid method evaluation for amyloid PET of subcortical vascular dementia
por: Yun, Hyuk Jin, et al.
Publicado: (2017)

Concordance in detecting amyloid positivity between (18)F-florbetaben and (18)F-flutemetamol amyloid PET using quantitative and qualitative assessments
por: Cho, Soo Hyun, et al.
Publicado: (2020)

Clinical outcomes of increased focal amyloid uptake in individuals with subthreshold global amyloid levels
por: Kim, Jaeho, et al.
Publicado: (2023)

Author Correction: Concordance in detecting amyloid positivity between (18)F-florbetaben and (18)F-flutemetamol amyloid PET using quantitative and qualitative assessments
por: Cho, Soo Hyun, et al.
Publicado: (2021)

(18)F-Florbetaben PET beta-amyloid binding expressed in Centiloids
por: Rowe, Christopher C., et al.
Publicado: (2017)

Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach
por: Royse, Sarah K., et al.
Publicado: (2021)

Considerations for Performing Level-2 Centiloid Transformations for Amyloid PET SUVR values
por: Schwarz, Christopher G., et al.
Publicado: (2018)

Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s disease
por: Amadoru, Sanka, et al.
Publicado: (2020)

(18)F-THK5351 PET Positivity and Longitudinal Changes in Cognitive Function in β-Amyloid-Negative Amnestic Mild Cognitive Impairment
por: Chun, Min Young, et al.
Publicado: (2022)

Predicting conversion of brain β-amyloid positivity in amyloid-negative individuals
por: Park, Chae Jung, et al.
Publicado: (2022)

Operationalizing the centiloid scale for [(18)F]florbetapir PET studies on PET/MRI
por: Coath, William, et al.
Publicado: (2023)

Distinct effects of cholesterol profile components on amyloid and vascular burdens
por: Kang, Sung Hoon, et al.
Publicado: (2023)

Prediction of amyloid β PET positivity using machine learning in patients with suspected cerebral amyloid angiopathy markers
por: Jung, Young Hee, et al.
Publicado: (2020)

Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes
por: Kim, Jun Pyo, et al.
Publicado: (2019)

Independent effect of body mass index variation on amyloid-β positivity
por: Kang, Sung Hoon, et al.
Publicado: (2022)

Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies
por: Su, Yi, et al.
Publicado: (2018)

Clinical effects of novel susceptibility genes for beta-amyloid: a gene-based association study in the Korean population
por: Kim, Bo-Hyun, et al.
Publicado: (2023)

Centiloid scaling for quantification of brain amyloid with [(18)F]flutemetamol using multiple processing methods
por: Battle, Mark R., et al.
Publicado: (2018)

A universal neocortical mask for Centiloid quantification
por: Bourgeat, Pierrick, et al.
Publicado: (2023)

Clinical significance of focal ß-amyloid deposition measured by (18)F-flutemetamol PET
por: Kim, Si Eun, et al.
Publicado: (2020)

Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers
por: Salvadó, Gemma, et al.
Publicado: (2019)

Gender-specific relationship between thigh muscle and fat mass and brain amyloid-β positivity
por: Kang, Sung Hoon, et al.
Publicado: (2022)

Development of software for measuring brain amyloid accumulation using (18)F‐florbetapir PET and calculating global Centiloid scale and regional Z‐score values
por: Matsuda, Hiroshi, et al.
Publicado: (2023)

Linguistic, visuospatial, and kinematic writing characteristics in cognitively impaired patients with beta-amyloid deposition
por: An, Seo Kyung, et al.
Publicado: (2023)

Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [(18)F] flutemetamol amyloid PET study
por: Hanseeuw, Bernard J., et al.
Publicado: (2020)

Cognitive trajectories of patients with focal ß-amyloid deposition
por: Kim, Si Eun, et al.
Publicado: (2021)

The effects of imaging markers on clinical trajectory in cerebral amyloid angiopathy: a longitudinal study in a memory clinic
por: Jang, Hyemin, et al.
Publicado: (2023)

Distinctive Temporal Trajectories of Alzheimer’s Disease Biomarkers According to Sex and APOE Genotype: Importance of Striatal Amyloid
por: Kim, Jun Pyo, et al.
Publicado: (2022)

Distinctive Mediating Effects of Subcortical Structure Changes on the Relationships Between Amyloid or Vascular Changes and Cognitive Decline
por: Jung, Na-Yeon, et al.
Publicado: (2021)

[(18)F]THK-5351 PET Patterns in Patients With Alzheimer’s Disease and Negative Amyloid PET Findings
por: Oh, Minyoung, et al.
Publicado: (2022)

Relationships between educational attainment, hypertension, and amyloid negative subcortical vascular dementia: The brain-battering hypothesis
por: Hwangbo, Song, et al.
Publicado: (2022)

Distinct amyloid distribution patterns in amyloid positive subcortical vascular cognitive impairment
por: Jang, Hyemin, et al.
Publicado: (2018)

Prediction of fast decline in amyloid positive mild cognitive impairment patients using multimodal biomarkers
por: Jang, Hyemin, et al.
Publicado: (2019)

Glycolysis on F-18 FDG PET/CT Is Superior to Amino Acid Metabolism on C-11 Methionine PET/CT in Identifying Advanced Renal Cell Carcinoma at Staging
por: Lee, Suk-Hyun, et al.
Publicado: (2021)

Diagonal Earlobe Crease is a Visible Sign for Cerebral Small Vessel Disease and Amyloid-β
por: Lee, Jin San, et al.
Publicado: (2017)

Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity
por: Chun, Min Young, et al.
Publicado: (2023)

Performance of the plasma Aβ42/Aβ40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort
por: Jang, Hyemin, et al.
Publicado: (2021)

Predicting amyloid positivity in patients with mild cognitive impairment using a radiomics approach
por: Kim, Jun Pyo, et al.
Publicado: (2021)

Identifying genetic variants for amyloid β in subcortical vascular cognitive impairment
por: Kim, Hang-Rai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h2j2hls75a18dpb8s6hkp2nv51